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Fatty acids (FA) exert physiological and pathophysiological effects leading to
changes in skeletal muscle metabolism and function, however, in vitro models to
investigate these changes are limited. These experiments sought to establish the
effects of physiological and pathophysiological concentrations of exogenous FA
upon the function of tissue engineered skeletal muscle (TESkM). Cultured initially
for 14 days, C2C12 TESkM was exposed to FA‐free bovine serum albumin alone or
conjugated to a FA mixture (oleic, palmitic, linoleic, and α‐linoleic acids [OPLA] [ratio
45:30:24:1%]) at different concentrations (200 or 800 µM) for an additional 4 days.
Subsequently, TESkM morphology, functional capacity, gene expression and insulin
signaling were analyzed. There was a dose response increase in the number and size
of lipid droplets within the TESkM (p < .05). Exposure to exogenous FA increased
the messenger RNA expression of genes involved in lipid storage (perilipin 2
[p < .05]) and metabolism (pyruvate dehydrogenase lipoamide kinase isozyme 4
[p < .01]) in a dose dependent manner. TESkM force production was reduced (tetanic
and single twitch) (p < .05) and increases in transcription of type I slow twitch fiber
isoform, myosin heavy chain 7, were observed when cultured with 200 µM OPLA
compared to control (p < .01). Four days of OPLA exposure results in lipid accu-
mulation in TESkM which in turn results in changes in muscle function and meta-
bolism; thus, providing insight ito the functional and mechanistic changes of TESkM
in response to exogenous FA.
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1 | INTRODUCTION
Skeletal muscle is a major site of carbohydrate and lipid utilization,
where efficient selection between these two substrates is paramount
in maintaining metabolic homeostasis (Stinkens et al., 2015). The
storage of fatty acids (FA) as triglycerides in skeletal muscle, which
are referred to as intramyocellular lipids (IMCL), are elevated in
skeletal muscle of trained endurance athletes (Amati et al., 2011).
These IMCL provide an important energy source (Amati et al., 2011;
Meex et al., 2009), yet paradoxically are associated with metabolic
diseases, such as obesity and Type 2 diabetes (Jacob et al., 1999).
Dietary FA and their impact upon skeletal muscle IMCL accu-
mulation and substrate metabolism is a highly debated area (Dirks
et al., 2020; Goodpaster, 2020). Both rodent and human studies have
shown that diets rich in FA can increase IMCL accumulation
(Bachmann et al., 2001; Whytock et al., 2020) which can impact
whole body metabolism, insulin sensitivity and glucose uptake
(Krssak et al., 1999; Parry et al., 2019; Savage et al., 2019).
In addition, rodent models have shown a reduction in skeletal
muscle quality and force production following high fat diet feeding
(Hurst et al., 2019; Tallis et al., 2017). However, evidence that this
translates to humans is lacking, although a relative reduction in
muscle force production in patients who are obese compared to their
lean peers has been observed (Abdelmoula et al., 2012; Hulens
et al., 2001; Maffiuletti et al., 2007). Therefore, understanding the
role of FA upon skeletal muscle metabolism and function using
in vivo and in vitro experiments is important for improving skeletal
muscle health and performance.
In vitro experiments, which are often in monolayer using cell
lines and primary skeletal muscle cells, have established several
short and long term adaptations to exogenous FA such as increased
lipid oxidation (Meex et al., 2015), mitochondrial biogenesis (Turner
et al., 2007) and the formation of lipid droplets (LD) as IMCL (Toledo
et al., 2018). However, understanding the impact of exogenous FA
upon skeletal muscle physiology and function in a monolayer culture
system is challenging. Therefore, the use of advanced cell culture
models can provide an alternative system which addresses some of
the limitations of monolayer culture such as the ability to investigate
the functional response of skeletal muscle to exogenous FA in vitro.
Advanced cell culture models, such as three dimensional tissue
engineered skeletal muscle (TESkM), have provided physiologists
with a tool to further enhance understanding of skeletal muscle
development and maturation, its interaction with an extracellular
matrix, and the impact of metabolic diseases, such as type 2 diabetes
(Acosta et al., 2020; Cheng et al., 2014; Hinds et al., 2011; Kondash
et al., 2020). Our research group, and others, have utilized TESkM to
investigate how changes in the nutritional milieu can augment or
attenuate skeletal muscle adaptation on both a molecular and
functional level (Khodabukus & Baar, 2015; Martin et al., 2017).
Despite the importance of FA in skeletal muscle metabolism (Badin
et al., 2013), quite how physiological and pathophysiological concentra-
tions of FA influence TESkM function is yet to be defined. In order to
offer some insight into these mechanisms, the TESkM model developed
by our research group (Capel et al., 2019), was exposed to physiological
and pathophysiological concentrations of FA which have previously been
shown to induce lipid accumulation in non‐adipose cell lines (Green
et al., 2015; Gunn et al., 2020; Hodson et al., 2008). This allowed in-
vestigation of the impact of FA overload upon LD formation, gene ex-
pression, insulin sensitivity, and functional capacity in TESkM.
2 | METHODS
2.1 | Skeletal muscle cell culture
C2C12 skeletal muscle myoblasts cells (ECACC 91031101, all below
passage 10) were cultured in growth medium (GM); composed of
high glucose Dulbecco's modified Eagle's medium (DMEM) (Thermo
Fisher Scientific), supplemented with 20% fetal bovine serum (Pan
Biotech Ltd), and 1% penicillin/streptomycin (P/S) (Thermo Fisher
Scientific). Cells were incubated in a 5% CO2 humidified atmosphere
at 37°C until 80%–90% confluence was attained, before being de-
tached from the culture vessel using trypsin–EDTA (Sigma‐Aldrich)
and counted in preparation for the formation of TESkM.
2.2 | Formation of tissue engineered skeletal
muscle (TESkM)
TESkM were generated using C2C12 myoblasts cells as outlined
previously by our group (Capel et al., 2019). TESkM were formed by
the addition of 65% vol/vol Type I rat tail collagen (First Link; dis-
solved in 0.1M acetic acid, protein at 2.035mg/ml), 20% vol/vol
Corning® Matrigel® Matrix (Thermo Fisher Scientific), with 10% vol/
vol of 10X minimal essential medium (Thermo Fisher Scientific). This
solution was subsequently neutralized by the addition of 5 and 1M
sodium hydroxide dropwise, until a color change to cirrus pink was
observed. The cells were added in a 5% vol/vol GM solution, before
being transferred to pre‐sterilized 3D printed inserts to set for
10–15min at 37°C. All relevant.stl files for the designs contained
within this manuscript are freely available to download at the fol-
lowing domain: https://figshare.com/projects/3D_Printed_Tissue_
Engineering_Scaffolds/36494. Constructs were cultured for 4 days
in GM, before being changed to differentiation media (DM) (DMEM,
2% horse serum (Thermo Fisher Scientific), 1% P/S) for a further
10 days.
2.3 | Fatty acid conjugation and fatty acid
exposure protocol
After a total of 14 days in culture, TESkM constructs were treated
with 0.25% FA‐free bovine serum albumin (FAF‐BSA) alone or con-
jugated to oleic, palmitic, linoleic, and α‐linoleic acid (OPLA)
(physiological ratio 45:30:24:1%) at a concentration of 200 and
800 µM, as used previously to induce lipid droplet accumulation in a
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non‐adipose cell line (Gunn et al., 2020). OPLA was supplemented
into high glucose, phenol red free DMEM with 2% horse serum,
4 mM L‐glutamine, 1 mM sodium pyruvate, and 1% P/S and were in
addition to the concentrations of albumin and triglycerides contained
in the horse serum. The control condition contained a concentration
of FAF‐BSA which was matched to the 800 µM condition. Constructs
were incubated for 4 days with the media changed 48 h before
termination of the experiment (Figure 1).
2.4 | Acute insulin stimulation
The culture media was changed 1 h before acute insulin stimulation
protocol. Constructs were washed twice in Krebs Ringer HEPES
(KRH) buffer (10mM HEPES pH 7.4, 138mM NaCl, 4.7 mM KCl,
1.25mM CaCl2, 1.25mMMgSO4, 5 mM glucose, and 0.05% BSA) and
incubated in KRH buffer for 30min twice before being stimulated for
30min in KRH with or without insulin (100 nM).
2.5 | Protein quantification and immunoblotting
Protein was extracted using RIPA lysis buffer (Sigma‐Aldrich) containing
a protease and phosphatase inhibitor cocktail mix (Thermo Fisher
Scientific). Lysis buffer was added to constructs before being mechani-
cally lysed using a tissue lyser (Qiagen). Lysates were placed on a rotor
for 1 h at 4°C to before being centrifuged at 12,000 g to further dissolve
the cellular and pellet insoluble material. Protein concentrations were
determined using the Pierce 660 nm protein assay (Thermo Fisher
Scientific), and an equal amount of protein was mixed with 4X Laemmli
buffer (Bio‐Rad), boiled for 5min at 95°C and separated by sodium
dodecyl sulfate‐polyacrylamide gel electrophoresis. Proteins were trans-
ferred onto nitrocellulose membranes (Thermo Fisher Scientific) and
blocked for 1 h at room temperature in 5% bovine serum albumin (BSA)
or 5% blocking grade milk (Bio‐Rad) in Tris‐buffered saline with Tween‐
20 (TBST), before being incubated with the primary antibody overnight
at 4°C in BSA or milk. Primary antibodies used for analysis were, Akt
(1:2000, #9272), phospho Akt (Ser473) (1:2000, #4060), and glycer-
aldehyde 3‐phosphate dehydrogenase (GAPDH) (1:5000, #2118) GSK‐3β
(1:2000, #9315) and phosphor GSK‐3β (Ser9) (1:2000, #9336) (Cell Sig-
naling Technology). Following overnight incubation, membranes were
washed in TBST and incubated with ant‐irabbit (GE healthcare)
horseradish peroxidase‐conjugated secondary antibody (1:5000) in
blocking grade milk (Bio‐Rad). Proteins were visualized using chemilu-
minescence substrate (Bio‐Rad) and band densities were quantified using
Quantity One image analysis software (Quality One 1‐D analysis soft-
ware version 4.6.8). Following visualization of phosphorylation proteins,
membranes were washed in TBST and incubated in stripping buffer
(Thermo Fisher Scientific) before being blocked and probed as outlined
above for their corresponding total proteins. Phosphorylation was nor-
malized to total protein with the exception of phospho AS160 (Ser588),
which was normalized to GAPDH.
2.6 | RNA extraction and qPCR analysis
RNA was extracted using TRI Reagent® (Sigma‐Aldrich) according to
manufacturer's instructions and quantified using UV spectroscopy
(NanoDrop; Thermo Fisher Scientific). Gene expression was analyzed by
one‐step reverse transcription‐quantitative polymerase chain reaction
(Quantifast SYBR Green Mix; Qiagen) using a Viia 7 thermocycler
(Applied Biosystems). Each reaction consisted of 5 ng of RNA in a final
10 µl reaction volume with master mixes made according to the manu-
facturer's instructions (Qiagen) and using primers sequences outlined in
Table S1. Fluorescence was detected after every cycle (40 cycles) and
data was analyzed using the 2‐ΔΔCt method (Schmittgen & Livak, 2008)
using RNA polymerase II beta (polr2b) as an endogenous control gene.
2.7 | Muscle function assessment
TESkM constructs were washed twice in phosphate‐buffered saline
(PBS) and one end of the construct was removed from the mold. The
loose end of the construct was then attached to the force transducer
(403A Aurora force transducer, Aurora Scientific) using the eyelet
present in the construct. The construct was covered (4ml) with KRH
buffer solution and wire electrodes were positioned either side of
the construct to allow for electric field stimulation. Impulses were
generated using LabVIEW software (National Instruments) con-
nected to a custom‐built amplifier. Maximal twitch force was de-
termined using a single 3.6 V/mm, 1.2 ms impulse and maximal
tetanic force was measured using a 1 s pulse train at 100 Hz and
3.6 V/mm. Data was acquired using a Powerlab system (ver. 8/35)
and associated software (Labchart 8, AD Instruments).
F IGURE 1 Experimental outline of development and exposure to exogenous fatty acid (FA) overload in 3D tissue engineered skeletal
muscle. DM, differentiation media; OPLA, oleic, palmitic, linoleic, and α‐linoleic acid
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2.8 | Cryosectioning
Following completion of the muscle function assessment, constructs
from each condition were washed in ice cold PBS before being fixed
in 3.7% formaldehyde (Sigma‐Aldrich). Fixed constructs were dehy-
drated in 20% sucrose (wt/vol) in Tris‐buffered saline (TBS) for 24 h.
Constructs were then embedded in Tissue‐Tek® optimum cutting
temperature mounting medium and frozen in isopentane at −80°C
for a minimum of 2 h. Once frozen, 15μm sections were prepared,
using standard cryostat protocols, perpendicular to the longitudinal
axis of the construct and mounted onto SuperFrost Plus™ Adhesion
Slides (Thermo Fisher Scientific) for immunocytochemistry.
2.9 | Immunocytochemistry
Sections were blocked and permeabilised (TBS, 5% goat serum, 0.1%
triton X‐100) for 1 h at room temperature before being incubated
overnight at 4°C in blocking solution containing myosin heavy chain
primary antibody at a concentration of 1:500 (MF 20 was deposited to
the DSHB by Fischman, D.A. [DSHB Hybridoma Product MF 20]). Sam-
ples were washed with TBS before being incubated for 1 h at room
temperature with secondary fluorescent conjugated antibody (1:500,
Invitrogen Alexa Fluor™ 647 goat antimouse), counterstained with DAPI
(1:2000) and Nile Red (NR) solution (1:1000, 1mg·ml in DMSO) to vi-
sualize LD. Slides were then washed and mounted using FluoromountTM
mounting medium (Sigma‐Aldrich). Images were collected on a Leica
DM2500 microscope using Leica Application Suite X software. Fiji 1.52e
(Schindelin et al. 2012) was used for image analysis, and an in‐house
macro performed automated myotube and lipid analysis macro which
was developed and has previous been used by our group (Aguilar‐Agon
et al., 2019; Fleming et al., 2020) un blinded to the researcher.
To establish if the LD observed by NR were intracellular or ex-
tracellular, colocalisation analysis was conducted with MHC images.
Images were converted to 16‐bit before co‐localization analysis
which was conducted using the FIJI plugin, Just Another Co‐
Localization Plugin (Bolte & Cordelières, 2006). The threshold
function was used to subjectively determine the myotubes and lipids
droplets. Threshold corrected Manders' coefficient using five images
per condition from three independent experiments.
2.10 | Statistical analysis
Data is presented as mean ± SEM from 3 to 5 constructs per condi-
tion. Statistical analysis was performed using IBM© SPSS© Statistics
version 23. One‐way analysis of variance (ANOVA) with Bonferroni
post hoc correction was used to identify significant differences be-
tween conditions. Statistical significance was set at p < .05.
3 | RESULTS
3.1 | Increases in lipid droplet size and number in
TESkM following exposure to increasing
concentrations of OPLA
To establish the presence of lipids in TESkM following exposure to
OPLA, cross sections were probed with NR to identify LD (Figure 2).
Image analysis showed that with increasing media concentration of
OPLA, there was a dose response in the number of droplets present
in the construct, with both 200 and 800 µM concentrations sig-
nificantly increasing the number of droplets (p < .05; Figure 3a). The
average LD area was also increased in a dose dependent manner,
F IGURE 2 Exposure to exogenous FA overload induces intracellular lipid droplet formation in 3D tissue engineered skeletal muscle.
Representative cross sections of tissue engineered skeletal muscle constructs (TESkM) cultured with (200 µM OPLA and 800 µM OPLA) or
without (0 µM OPLA) endogenous lipids for 4 days probed for pan myosin heavy chain (MHC) (Green), lipid droplets (Nile Red [NR], Magenta)
and nuclei (DAPI, blue). Scale bar = 50 µm. DAPI, 4′,6‐diamidino‐2‐phenylindole; FA, fatty acid; OPLA, oleic, palmitic, linoleic, and α‐linoleic acid
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with only the 800 µM concentration being significantly increased
compared to 0 and 200 µM, respectively (p < .05; Figure 3b).
To establish if the lipid droplets were intracellular or extra-
cellular, colocalisation analysis was performed using a macro which
has been previously published (Bolte & Cordelières, 2006). Using a
threshold value to outline lipid droplets and myotubes, the Manders'
coefficient of lipid droplets which overlapped with MHC increased
with OPLA concentrations (M1 0.197, 0.219, and 0.326 for 0, 200,
and 800 µM conditions, respectively) with a significant difference
between 0 and 800 µM conditions (p < .05; Figure 3c).
3.2 | Increased TESkM construct size but reducing
in MHC coverage following exposure to increasing
concentrations of OPLA
Exposure to exogenous FA did not alter the average number of
myotubes per construct or average crosssectional area of the myo-
tubes (p > .05; Figure 4a,b). However, on average the overall TESkM
construct cross sectional area increased in response to 200 µM
OPLA (p < .05; Figure 4c) and to an extent in 800 µM compared to
control (p = .06). Consequently the MHC coverage, which was de-
fined as the percentage area of the construct expressing MHC, and
average myotubes per mm2, were lower in response to both con-
centrations of OPLA (p < .001; Figure 4d,e).
3.3 | Attenuated TESkM force production with the
addition of OPLA
Using a TESkM system enabled investigation of the functional ca-
pacity of skeletal muscle tissue to be investigated in response to
OPLA supplementation. Increasing concentrations of OPLA resulted
in a significant reduction in absolute maximal force generation (te-
tanic force) when exposed to 200 μM compared to control (p < .05),
with a trend toward a (p = .05) reduction in force of TESkM following
800 μM compared to control (Figure 5a). Single contraction (twitch)
force production showed a similar pattern to tetanic force responses
and was significantly lower when exposed to 200 μM (p < .05) and
had a tendency (p = .05) to be lower in the higher concentration of
OPLA (Figure 5b).
There were no differences in the messenger RNA (mRNA) ex-
pression of Myh1 (Type IIx) or Myh2 (Type IIa) fast twitch isoforms
between conditions (p > .05). The slow twitch isoform, Myh7, in-
creased in both conditions, with a two‐fold difference between 0 and
200 µM OPLA (p < .001). The mRNA expression of the Myh3 (em-
bryonic) was lower between 200 µM compared to 0 µM OPLA
(p < .05), with Myh8 (Perinatal) expression elevated in 200 µM com-
pared to 0 µM (p = .06) and significantly higher compared to con-
structs exposed to 800 µM OPLA (p < .05; Figure 5c).
3.4 | OPLA modulates expression of fatty acid
storage and oxidation regulatory mRNAs
Following 4 days of exposure to the different concentrations of
OPLA, the mRNA expression of markers that regulate lipid meta-
bolism were analyzed. An increase in the concentration of OPLA led
to a significant (p < .01) increase in mRNA expression of Pdk4. The
lipid droplet marker, Pnpla2 was significantly (p < .05) increased fol-
lowing exposure to 200 µM OPLA compared to control, however, no
differences between these conditions were observed compared to
exposure of 800 µM OPLA (p > .05; Figure 6a). The increase in OPLA
concentrations did result in a significant (p < .01) increase in the
expression of LD marker Perilipin 2 (Plin2) over control, with no
differences in the expression of Perilipin 5 (Plin5) mRNA between
conditions (p > .05). Sterol regulatory element binding transcription
factor 1 (Srebptf1) expression was lower in constructs incubated in
800 µM OPLA (p = .09), while cd36 was not different between con-
ditions (Figure 6a).
In addition, constructs were analyzed for the mRNA expression
of the Peroxisome proliferator‐activated receptor (Ppar) isoforms
which are key transcriptional factors involved in the metabolism of
FA. However, after short term exposure to exogenous FA did not
F IGURE 3 Exposure to exogenous FA overload increases the presence of intracellular lipid droplet in 3D tissue engineered skeletal muscle.
Lipid droplet (LD) (Nile Red) image analysis (a, number of LD; b, average LD area) from skeletal muscle tissue engineered construct cross
sections. (c) Colocalisation analysis using Manders' coefficient of Nile Red which overlapped with MHC. Data is presented as mean ± SEM.
Significantly different versus 0 µM, (*p < .05, †p < .01), significantly different versus 200 µM (‡p < .05). FA, fatty acid; MHC, myosin heavy chain;
OPLA, oleic, palmitic, linoleic, and α‐linoleic acid
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alter the mRNA expression of any of the Ppar isoforms (Pparα, Pparδ,
Pparγ) or peroxisome proliferator‐activated receptor gamma coacti-
vator 1‐alpha (Pgc‐1α) (p > .05; Figure 6b).
3.5 | Insulin signaling responses to OPLA exposure
Insulin stimulated Akt (Ser473) phosphorylation was not different
between conditions (p > .05; Figure 7a), however insulin stimulated
phosphorylation of AS160 (Ser588) and GSK‐3β (Ser9) relative to
basal was attenuated with OPLA exposure between 0 and 800 µM
OPLA (p < .05; Figure 7b,c).
4 | DISCUSSION
The use of TESkM to investigate the physiological and functional
responses to nutritional substrates is well documented (Khodabukus
& Baar, 2015; Khodabukus et al., 2007; Martin et al., 2017). Despite
the role of FA in skeletal muscle physiology and pathophysiology
(Meex et al., 2009), advanced in vitro models, such as TESkM, which
enable investigation of both the molecular and functional responses
to exogenous FA have yet to be utilized. Therefore, these experi-
ments sought to determine if exposure to a mixture of FA would
affect the accumulation of lipids within TESkM constructs, and ulti-
mately alter the molecular and functional response of the construct.
Both skeletal muscle tissue and skeletal muscle cells have been
shown to readily increase FA uptake in response to FA exposure (Bonen
et al., 2004; Newsom et al., 2015). Using concentrations which have
previously been shown to increase the accumulation of FA in C2C12 and
primary skeletal muscle cells (Newsom et al., 2015), these experiments
showed a dose dependent increase in the presence of lipids droplets in
TESkM. Although we did not quantify TAG or diglyceride directly, it could
be speculated that the increase in number and size of the LD in TESkM
reflect an accumulation of neutral lipids, such as TAGs, previously shown
in rodent skeletal muscle tissue and skeletal muscle cells (Lee et al., 2006;
Newsom et al., 2015).
Based on the morphological findings that exogenous FA in-
creased both the number and size of LD within our TESkM, we
analyzed the mRNA expression of plin2 and plin5, which are key
F IGURE 4 Exposure to exogenous FA overload alters myosin
heavy chain coverage in 3D tissue engineered skeletal muscle
skeletal muscle (MHC) image analysis (a, MHC coverage; b, myotubes
per construct; c, Myotubes per mm2; d, construct crosssectional area
[CSA] [μm]; e, Avg. Myotubes CSA [μm2]) skeletal muscle tissue
engineered construct cross sections. Data is presented as
mean ± SEM. Significantly different versus 0 µM. FA, fatty acid; MHC,
myosin heavy chain; OPLA, oleic, palmitic, linoleic, and α‐linoleic acid.
*p < .05, ***p < .001
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regulators of LD storage and mobilization in skeletal muscle (Bosma
et al., 2012; Feng et al., 2017). Specifically plin2 expression, which
was increased in these experiments with increasing concentrations
of OPLA, has been confirmed previouslyin vitro in response to sa-
turated and unsaturated FA (Bosma et al., 2012). However, despite
its role in lipid metabolism (Mason & Watt, 2015), there were no
increases in plin5 expression with exogenous FA. The disparity be-
tween our findings and previous in vitro studies, which have shown
FA to increase plin5 in C2C12 cells overexpressing this gene
(Bindesbøll et al., 2013), is potentially related to the low endogenous
levels of plin5 in this cell type (Daemen et al., 2018; Mason &
Watt, 2015).
With the increased LD in our TESkM when cultured with exo-
genous FA, pdk4 increased in a dose dependent manner. Increases in
pdk4 expression and activity are indicative of changes in nutritional
status, such as increased exposure to lipids that induce metabolic
switching toward FA metabolism. This is achieved through the pyr-
uvate dehydrogenase complex and is correlated with PDK activity in
skeletal muscle (Rodríguez et al., 2010). The increase in pdk4 mRNA
has been reported previously in human skeletal muscle cells obtained
from healthy donors and patients who are obese and diabetic ex-
posed to FA overload (McAinch et al., 2015), which although not
directly measured in this system, indicates a potential metabolic shift
in response to exposure of FA (Peters et al., 2001).
In skeletal muscle, exogenous FA are initially trafficked towards
storage with the breakdown of LD mediated by lipases, such as adipose
triglyceride lipase (ATGL) which is encoded by the pnpla2 gene (Ji
et al., 2006). pnpla2 expression has been observed in human and rodent
skeletal muscle (Sitnick et al., 2013), and to a lesser extent in C2C12
skeletal muscle cells (Meex et al., 2015). We observed only small increase
F IGURE 5 Exogenous FA overload induces functional changes in
3D tissue engineered skeletal muscle and alters myosin heavy chain
messenger RNA (mRNA) expression. Force Analysis (a, tetanus and b,
twitch) and (c), Mhc gene expression of skeletal muscle tissue
engineered constructs cultured with different concentrations of
OPLA. Data is presented as mean ± SEM. Significantly different
versus 0 µM *(p < .05), ***(p < .001). Significantly different versus
200 µM (‡p < .05). FA, fatty acid; OPLA, oleic, palmitic, linoleic, and
α‐linoleic acid
F IGURE 6 Exogenous FA overload alters mRNA expression of
genes involved in lipid metabolism of 3D tissue engineered skeletal
muscle. (a) Expression of lipid metabolism genes following exposure
to OPLA for. (b) Peroxisome proliferator‐activated receptor (Ppar)
isoform mRNA expression following exposure to OPLA for 4 days.
Data is presented as mean ± SEM. Significantly different versus 0 µM
*(p < .05, **p < .01, ***p < .001). FA, fatty acid; mRNA, messenger
RNA; OPLA, oleic, palmitic, linoleic, and α‐linoleic acid
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in pnpla2 expression with exogenous FA in this system which does not
follow the trends in pnpla2 (AGTL) protein expression with exogenous
FAs (Newsom et al., 2015). Newsom and colleagues observed increases
in AGTL protein expression following shorter incubation periods with FA
that would suggest the translation to protein occurs within a relatively
short period of time, with transcription preceding the increase in protein
expression (Newsom et al., 2015). In addition, it is important to note that
genes such as the lipid activated transcriptional factors, Ppars, are acti-
vated by dietary FA (Lee et al., 2003). Therefore, the transient expression
of these transcription factors would account for the small changes ob-
served in these experiments whereby the incubation time spanned the
transcriptional peak of these genes in response to exogenous FA, which
has been observed in C2C12 skeletal muscle cells (Rodríguez
et al., 2010).
The impact of lipid accumulation IMCL on skeletal muscle insulin
sensitivity is a highly debated area (Dirks et al., 2020;
Goodpaster, 2020). Using a mixture of FA to mimic systemic con-
centrations has previously been shown to alter insulin signalling in
hepatocytes and skeletal muscle cells using conventional culture
methods (Green et al., 2015; Hodson et al., 2008; Newsom
et al., 2015). We observed there to be a significant reduction in
insulin stimulated phosphorylation of proximal insulin signaling
proteins AS160 and GSK‐3β, although no significant reductions in
Akt phosphorylation. The reductions observed in our experiments
coincide with the modest reductions previously reported in skeletal
muscle cells exposed to normal mixtures of FA (Newsom et al., 2015).
A number of factors could contribute to this response, such as the
cellular location of lipids and the type of lipids to which skeletal
muscle is exposed. For example, the addition of polyunsaturated FA
has been shown to have beneficial effects upon saturated FA induced
insulin resistance (Lee et al., 2006) by driving an increase in TAG
accumulation (Lee et al., 2006; Newsom et al., 2015). While some
observed trends indicated changes in insulin signaling, these re-
sponses can occur following adaptions to, and increases in, IMCL
following high fat diet feeding in skeletal muscle (Bonen et al., 2015).
Unlike monolayer culture methods, TESkM enables for investigation
of the functional changes in skeletal muscle contraction in response to
nutritional or electrical stimulation (Khodabukus et al., 2015; Martin
et al., 2017). Furthermore, this in vitro model allows the maintenance of
TESkM for prolonged culture periods (>14 days) and provides the flex-
ibility to investigate the progressive metabolic changes to lipid exposure
in skeletal muscle (Khodabukus & Baar, 2009; Madden et al., 2015). The
absolute reduction in maximal tetanic and single twitch force in response
to lipid exposure, despite an increase in construct size, could be attrib-
uted to changes in skeletal muscle fiber type which have been reported
in rodent skeletal muscle following the feeding of dietary FA (Eshima
et al., 2017; Shortreed et al., 2009). We analyzed the mRNA expression
of myosin heavy chain isoforms, which identified a small but statistically
significant increase in transcription of slow (myh7) type I fibers. This has
previously been reported in rodents, and has been shown to have ne-
gative effects upon skeletal muscle force generation following short term
dietary FA interventions (de Wilde et al., 2008; Tallis et al., 2018).
However, other factors such as metabolic phenotype (Ciapaite
et al., 2015; Tallis et al., 2017) and calcium handling (Bruton et al., 2002;
Warmington et al., 2000), have been shown to contribute to changes in
skeletal muscle force capacity with FA exposure and cannot be dis-
counted as a contributing factor to the findings from these experiments.
It should be noted that exposure to OPLA, independent of concentration,
induced similar decrements in force generation compared to 0μM. Al-
though we are unable to specifically identify the reason for these find-
ings, this is an area requiring further investigation to understand how
exogenous FA influences force transmission through changes in ECM
expression and the implications it has for patients who are insulin re-
sistant (Berria et al., 2006; Richardson et al., 2005).
Although our findings provide insight into some of the molecular
responses to exogenous FA in TESkM, it is important to note that the
changes in gene expression are not always representative of protein
content or function. While our data provides evidence of the accu-
mulation of lipids, further experiments are required to identify the
neutral or bioactive lipid intermediates derived from exogenous
F IGURE 7 Insulin signaling response of 3D tissue engineered skeletal muscle in response to exogenous FA overload. Immunoblot analysis
for (a) Akt, (b) AS160, (c) GSK‐3β, and (d) representative images of insulin signaling proteins in response to acute insulin stimulation
(±100 nM for 30min) following exposure to different concentrations of OPLA. Data is presented as mean ± SEM of the fold change to basal
stimulation. Significantly different versus 0 µM *(p < .05). FA, fatty acid; OPLA, oleic, palmitic, linoleic, and α‐linoleic acid
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sources, as well as the cellular location of FA, as both are important
factors in skeletal muscle insulin sensitivity (Amati et al., 2011;
Bergman et al., 2012; Perreault et al., 2018). The relatively short
term exposure to the physiological and pathophysiological con-
centrations are representative of an initial adaptation to increases in
exogenous FA. However, the effects of long‐term exposure are yet to
be defined in our model, as prolonged exposure to FA could result in
an exacerbated pathophysiological change in TESkM, similar to that
observed in mouse skeletal muscle in vivo (Eshima et al., 2017).
Our findings show that TESkM is responsive to different con-
centrations of exogenous FA, through the increase in accumulation
of lipids in the construct, as well as increased expression of genes
involved in lipid breakdown and oxidation. These changes are ac-
companied by adaptations in the expression of myosin heavy chain
isoforms that may contribute to the absolute reduction in functional
capacity of TESkM in response to short term FA exposure. This study
describes an advanced 3D cell culture model to investigate the im-
pact of exogenous FA upon skeletal muscle physiology and function.
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